Legal & General Group PLC I Mab Transaction History
Legal & General Group PLC
- $470 Billion
- Q3 2024
A detailed history of Legal & General Group PLC transactions in I Mab stock. As of the latest transaction made, Legal & General Group PLC holds 1,191 shares of IMAB stock, worth $1,167. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,191
Previous 1,191
-0.0%
Holding current value
$1,167
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
About I-Mab
- Ticker IMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,098,800
- Market Cap $81.4M
- Description
- I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...